IQVIA Holdings Inc
NYSE:IQV

Watchlist Manager
IQVIA Holdings Inc Logo
IQVIA Holdings Inc
NYSE:IQV
Watchlist
Price: 201.82 USD 2.14% Market Closed
Market Cap: 36.7B USD
Have any thoughts about
IQVIA Holdings Inc?
Write Note

IQVIA Holdings Inc
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IQVIA Holdings Inc
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
IQVIA Holdings Inc
NYSE:IQV
Intangible Assets
$4.7B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
32%
Thermo Fisher Scientific Inc
NYSE:TMO
Intangible Assets
$16.3B
CAGR 3-Years
11%
CAGR 5-Years
3%
CAGR 10-Years
1%
Danaher Corp
NYSE:DHR
Intangible Assets
$19.9B
CAGR 3-Years
-5%
CAGR 5-Years
12%
CAGR 10-Years
12%
West Pharmaceutical Services Inc
NYSE:WST
Intangible Assets
$12.3m
CAGR 3-Years
-22%
CAGR 5-Years
-16%
CAGR 10-Years
-12%
Mettler-Toledo International Inc
NYSE:MTD
Intangible Assets
$262.5m
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Intangible Assets
$392m
CAGR 3-Years
-28%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
No Stocks Found

IQVIA Holdings Inc
Glance View

Market Cap
36.7B USD
Industry
Life Sciences Tools & Services

IQVIA Holdings Inc. stands at the crossroads of healthcare and technology, blending innovative data analytics with deep industry expertise to enhance the clinical development and commercialization of pharmaceuticals. Founded in 2016 from the merger of IMS Health and Quintiles, IQVIA has rapidly positioned itself as a leader within the life sciences sector. The company's core mission revolves around leveraging vast sources of healthcare data and advanced artificial intelligence to provide actionable insights, streamline drug development processes, and facilitate improved patient outcomes. With a global footprint extending across more than 100 countries, IQVIA serves a diverse clientele, including biopharmaceutical companies, healthcare providers, and government organizations, making it a pivotal player in the ever-evolving healthcare landscape. For investors, IQVIA represents a compelling opportunity that combines robust financial performance with strong market demand driven by the growing complexities of drug development and regulatory environments. As the healthcare sector increasingly turns to data-driven decision-making, IQVIA's extensive suite of services—including real-world evidence, market access solutions, and technology-enabled clinical trial services—positions it favorably in a market ripe for innovation. The company's commitment to research and development, coupled with strategic partnerships and acquisitions, fuels its long-term growth trajectory. Furthermore, IQVIA's resilience in navigating industry shifts, highlighted by its consistent revenue growth and healthy profit margins, reflects a business model that is not only scalable but also agile enough to adapt to the challenges and opportunities of modern medicine.

IQV Intrinsic Value
259.71 USD
Undervaluation 22%
Intrinsic Value
Price

See Also

What is IQVIA Holdings Inc's Intangible Assets?
Intangible Assets
4.7B USD

Based on the financial report for Sep 30, 2024, IQVIA Holdings Inc's Intangible Assets amounts to 4.7B USD.

What is IQVIA Holdings Inc's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
32%

Over the last year, the Intangible Assets growth was -4%. The average annual Intangible Assets growth rates for IQVIA Holdings Inc have been -1% over the past three years , -3% over the past five years , and 32% over the past ten years .

Back to Top